Details

Application number :
18294  
Application type :
Standard  
Application status :
CEASED  
Under opposition :
No  
Proceeding type :
 
Invention title :
Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors  
Inventor :
Myers, Michael R. ; Maguire, Martin P. ; Spada, Alfred P. ; He, Wei  
Agent name :
WATERMARK PATENT AND TRADE MARKS ATTORNEYS  
Address for service :
Level 2 302 Burwood Road HAWTHORN VIC 3122  
Filing date :
23 November 1999  
Associated companies :
 
Applicant name :
Aventis Pharmaceuticals Inc.  
Applicant address :
55 Corporate Drive, Bridgewater, New Jersey, 08807 United States Of America  
Old name :
Aventis Pharmaceuticals Products Inc.  
Original Source :
Go  

Same Inventor